HB516
Health insurance; coverage for non-opioid prescription drugs.
Status:
In House
Latest Action:
Feb. 3, 2026
House: Subcommittee recommends laying on the table (5-Y 4-N)
Chief Patron:
Marty Martinez (D)
Session:
2026 Regular Session
Summary
As Introduced. Health insurance; coverage for non-opioid prescription drugs.
Prohibits a health insurance carrier from imposing any cost-sharing, prior authorization, step therapy, or other limitation on coverage of a covered non-opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain that is more restrictive or less favorable to the enrollee relative to ... (More) a covered opioid drug approved by the U.S. Food and Drug Administration for the treatment or management of pain. (Less)-
Bill History
- 01/13/2026 - House: Prefiled and ordered printed; Offered 01-14-2026 26101109D
- 01/13/2026 - House: Referred to Committee on Labor and Commerce
- 01/19/2026 - House: Assigned HCL sub: Subcommittee #1
- 01/27/2026 - House: Fiscal Impact Statement from Department of Planning and Budget (HB516)
- 01/30/2026 - House: Placed on Labor and Commerce Agenda
- 02/03/2026 - House: Subcommittee recommends laying on the table (5-Y 4-N)
